首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.
【24h】

Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.

机译:同源和异源偏见5-HT3受体配体识别位点的计算分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Inhibition of the 5-hydroxytryptamine receptor (5-HT(3)R), a member of the Cys-loop superfamily of Ligand-Gated Ion Channels (LGICs), has been recognized to have important antiemetic effects. With respect to the many other drugs already in use, such as the first generation 5-HT(3)R antagonist granisetron, palonosetron, a second generation antagonist, clearly demonstrates superior inhibition potency towards the 5-HT(3)Rs. Five different receptor monomers, the 5-HT(3)R A-E, have been identified although the A and B subunits are the only known to build functional receptors, the homopentameric 5-HT(3A)R and the heteropentameric 5-HT(3B-A)R (with BBABA subunit arrangement). At present, however, no three-dimensional structure has been reported for any of the 5-HT(3)R subunits. To understand the binding properties of agonists and antagonists, models of the extracellular portion of the 5-HT(3)R A and B subunits are built and assembled into the receptor (homo- and hetero-) pentameric structure on the basis of the known three-dimensional structure of the nicotinic-acetylcholine receptor (nACh-R). The results of docking studies of the natural agonist serotonin and the antagonists palonosetron and granisetron into the modelled homomeric and heteromeric 5-HT(3)R binding interfaces, provide a possible rationalization both of the higher potency of palonosetron with respect to other antagonists, and of its previously reported allosteric binding and positive cooperativity properties.
机译:已经认识到抑制5-羟基 - 羟基氨基受体(5-HT(3)r),伴有配体 - 门通道(LGICS)的综合共产物的成员,具有重要的止吐作用。关于已经使用的许多其他药物,例如第一代5- HT(3)抗拮抗剂格兰司琼,Palonosetron,第二代拮抗剂,清楚地证明了朝向5-HT(3)Rs的优异的抑制效力。已经鉴定了五种不同的受体单体,5-HT(3)R AE,但是唯一已知构建功能受体,均昆大胺5-HT(3A)R和异源大胺5-HT(3B -A)R(BBABA亚基排列)。然而,目前,任何5-HT(3)个亚基的任何三维结构都没有报道。为了了解激动剂和拮抗剂的结合特性,在已知的三个基础上,构建和组装成和组装成和组装成受体(均匀和异质和异)五聚体结构的细胞外部分的模型烟碱 - 乙酰胆碱受体的二维结构(NACH-R)。天然激动剂血清素和拮抗剂PalonoSetron和Granisetron与模拟的均匀和异统5-HT(3)r结合界面的对接研究结果提供了可合作的Palonosetron关于其他拮抗剂的较高效力,以及其先前报道的颠覆性结合和正合作性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号